Tonix Pharma Files 2025 Proxy Statement
Ticker: TNXP · Form: DEF 14A · Filed: Mar 31, 2025 · CIK: 1430306
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
TL;DR
Tonix Pharma's proxy statement is out, detailing exec pay and governance for 2024.
AI Summary
Tonix Pharmaceuticals Holding Corp. filed its DEF 14A proxy statement on March 31, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. The company, previously known as Tamandare Explorations Inc., is incorporated in Nevada and operates in the pharmaceutical preparations sector.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation and voting matters, enabling informed participation in the company's governance.
Risk Assessment
Risk Level: medium — DEF 14A filings are routine but can reveal changes in executive compensation or governance that may impact investor confidence.
Key Numbers
- 20250331 — Filing Date (Indicates when the proxy statement was submitted to the SEC.)
- 2024-12-31 — Fiscal Year End (The period covered by the financial and compensation information in the filing.)
Key Players & Entities
- Tonix Pharmaceuticals Holding Corp. (company) — Filer
- Tamandare Explorations Inc. (company) — Former Company Name
- 26 MAIN STREET, SUITE 101 (address) — Business and Mail Address
- CHATHAM, NJ 07928 (address) — Business and Mail Address
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, or Definitive Proxy Statement, is used to solicit proxies from shareholders and provide them with information about matters to be voted on at a shareholder meeting, including executive compensation, director elections, and other corporate actions.
When was Tonix Pharmaceuticals Holding Corp. formerly known as?
Tonix Pharmaceuticals Holding Corp. was formerly known as TAMANDARE EXPLORATIONS INC., with a name change date of March 20, 2008.
What is the business address of Tonix Pharmaceuticals Holding Corp.?
The business address is 26 MAIN STREET, SUITE 101, CHATHAM, NJ 07928.
What is the Standard Industrial Classification (SIC) code for Tonix Pharmaceuticals Holding Corp.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
What is the SEC file number for Tonix Pharmaceuticals Holding Corp.?
The SEC file number is 001-36019.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 31, 2025 regarding Tonix Pharmaceuticals Holding Corp. (TNXP).